Table 1.

Clinical Characteristics of Post-Mortem Specimens in this Study

Specimen	Age, Ethnicity, Gender	Height, Weight	COD	Comorbidities	Medications	Tissue Harvest
Control	52, C, M	69/242	CA	Tobacco use	Inhaler	14.9
Control	30, C, F	63/251	RF	Asthma, COPD	Advair	13.7–13.9
Control	36, C, M	65/319	MI	NIDDM, Asthma	–	16.3
Control	56, C, M	−/264	CA	COPD, Tobacco use	–	21.9
Control	52, C, M	72/205	CA	NIDDM	–	14.9–15.8
Control	47, H, F	68/167	RF	NIDDM, HTN, SA Tobacco use	–	16.8
Control	47, C, M	−/220	CA	Hx: 5 MI, HTN, CAD GERD, 12 Catheterizations, Tobacco, Alcohol use	Carvedilol	13.4–13.8
Control	64, AA, M	72/180	CA	Alcohol, Tobacco use	Metformin	17.3
				NIDDM	Glimepiride
Patient	37, C, M	70/220	SUDEP	SSADH Def.	Risperidone	~74

Height, inches; weight, pounds; all control tissues, and patient, were screened for infectious disease (HIV, syphilis, hepatitis B and C), with negative results. Tissue harvest refers to hours between death and tissue procurement. Abbreviations: C, Caucasian; H, Hispanic; AA, African American; COD, cause of death; MI, myocardial infarction; SUDEP, sudden unexplained death in epilepsy; NIDDM, non-insulin dependent diabetes mellitus; COPD, chronic obstructive pulmonary disease; HTN, hypertension; SA, sleep apnea; CAD, coronary artery disease; CA, cardiac arrest; RF, respiratory failure; SSADH def., succinic semialdehyde dehydrogenase deficiency; Hx, history